Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Pharmacokinetic analysis of pralidoxime after its intramuscular injection alone or in combination with atropine-avizafone in healthy volunteers

Abstract :

BACKGROUND AND PURPOSE

Treatment of organophosphate poisoning with pralidoxime needs to be improved. Here we have studied the pharmacokinetics of pralidoxime after its intramuscular injection alone or in combination with avizafone and atropine using an auto-injector device.

EXPERIMENTAL APPROACH

The study was conducted in an open, randomized, single-dose, two-way, cross-over design. At each period, each subject received either intramuscular injections of pralidoxime (700 mg), or two injections of the combination: pralidoxime (350 mg), atropine (2 mg), avizafone (20 mg). Pralidoxime concentrations were quantified using a validated LC/MS-MS method. Two approaches were used to analyse these data: (i) a non-compartmental approach; and (ii) a compartmental modelling approach.

KEY RESULTS

The injection of pralidoxime combination with atropine and avizafone provided a higher pralidoxime maximal concentration than that obtained after the injection of pralidoxime alone (out of bioequivalence range), while pralidoxime AUC values were equivalent. Pralidoxime concentrations reached their maximal value earlier after the injection of the combination. According to Akaike and to goodness of fit criteria, the best model describing the pharmacokinetics of pralidoxime was a two-compartment with a zero-order absorption model. When avizafone and atropine were injected with pralidoxime, the best model describing pralidoxime pharmacokinetics becomes a two-compartment with a first-order absorption model.

CONCLUSIONS AND IMPLICATIONS

The two approaches, non-compartmental and compartmental, showed that the administration of avizafone and atropine with pralidoxime results in a faster absorption into the general circulation and higher maximal concentrations, compared with the administration of pralidoxime alone.

Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal.univ-angers.fr/hal-03332277
Contributeur : Okina Université d'Angers <>
Soumis le : jeudi 2 septembre 2021 - 15:39:01
Dernière modification le : vendredi 3 septembre 2021 - 03:33:00

Lien texte intégral

Identifiants

Collections

Citation

Chadi Abbara, J.-M. Rousseau, Bénédicte Lelièvre, Alain Turcant, Guy Lallement, et al.. Pharmacokinetic analysis of pralidoxime after its intramuscular injection alone or in combination with atropine-avizafone in healthy volunteers. British Journal of Pharmacology, 2010, 161 (8), pp.1857-1867. ⟨10.1111/j.1476-5381.2010.01007.x⟩. ⟨hal-03332277⟩

Partager

Métriques

Consultations de la notice

6